July 2, 2025
TOPLINE: Among Medicare beneficiaries with HIV, the proportion receiving at least one nonrecommended antiviral prescription decreased substantially from 5.1% in 2013 to 0.1% in 2021. METHODOLOGY: […]
June 24, 2025
While several cancers associated with immunosuppression are much more common in White men who have sex with men living with HIV (MSMWH) than in the male […]
June 20, 2025
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended an extension of indication for dapivirine vaginal ring 25 mg to […]
June 18, 2025
TOPLINE: The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from sub-Saharan Africa. Its ability […]
June 16, 2025
TOPLINE: Posttraumatic stress disorder (PTSD) among veterans living with HIV significantly increased the risk for AIDS and multiple comorbidities, particularly arthritis, cardiovascular disease (CVD), chronic obstructive […]
June 4, 2025
TOPLINE: Nearly 12% of individuals using preexposure prophylaxis (PrEP) for HIV prevention, were diagnosed with alcohol use disorder (AUD) within 6 months of initiating PrEP, whereas […]
May 28, 2025
TOPLINE: A recent study found that antiretroviral therapy adherence below 90% was associated with significantly lower odds of viral suppression among women living with HIV. METHODOLOGY: […]
May 23, 2025
The European Medicines Agency (EMA) has given a positive opinion to a generic medicine, emtricitabine/tenofovir alafenamide, for the treatment of adults and adolescents infected with HIV […]
May 14, 2025
Cuts to HIV programming are affecting local prevention programs across the United States, but the potential impacts on public health and healthcare costs are especially high […]